Detalles de la búsqueda
1.
A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib.
Haematologica
; 107(11): 2630-2640, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443563
2.
Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.
Qual Life Res
; 31(3): 937-950, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518988
3.
Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey.
BMC Womens Health
; 18(1): 22, 2018 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29347935
4.
Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events.
J Oncol Pharm Pract
; 24(6): 412-423, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28614980
5.
Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.
Reprod Health
; 14(1): 70, 2017 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28595627
6.
Effects of tislelizumab on health-related quality of life in patients with recurrent or metastatic nasopharyngeal cancer.
Head Neck
; 2024 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38671587
7.
Disparity in treatment patterns among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia: an analysis of patient and contextual factors.
Leuk Lymphoma
; 65(5): 598-608, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323907
8.
Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia.
J Manag Care Spec Pharm
; 30(5): 430-440, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38701030
9.
The effects of tislelizumab treatment on the health-related quality of life of patients with advanced non-small cell lung cancer.
Cancer Med
; 12(16): 17403-17412, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37587845
10.
Impact of atrial fibrillation in onco-hematological patients in Europe: a targeted literature review.
Expert Rev Hematol
; 16(8): 617-627, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306506
11.
A real-world study to assess the association of cardiovascular adverse events (CVAEs) with ibrutinib as first-line (1L) treatment for patients with chronic lymphocytic leukaemia (CLL) in the United States.
EJHaem
; 4(1): 135-144, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36819172
12.
Correction to: Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.
Reprod Health
; 14(1): 126, 2017 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28985748
13.
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non-Small Cell Lung Cancer.
Cancer J
; 28(2): 96-104, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35333492
14.
Real-World longitudinal practice patterns in the use of PD-1 and PD-L1 inhibitors as First-Line therapy in patients with Non-Small cell lung cancer in the United States.
Cancer Med
; 11(22): 4265-4272, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35499294
15.
Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer Perspective.
J Manag Care Spec Pharm
; 25(1): 94-101, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084301
16.
Analysis of patient and nurse preferences for self-administered FSH injection devices in select European markets.
Int J Womens Health
; 11: 11-21, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30662286
17.
Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review.
Clin Ther
; 41(8): 1576-1588, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31151814
18.
Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis.
Clin Ther
; 30(7): 1375-84, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18691998
19.
Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.
J Manag Care Pharm
; 14(4): 352-62, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18500913
20.
The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.
Cardiol Rev
; 14(1): 7-13, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16371760